Compatibility and biodegradability are two very important factors for the success of bone graft procedures. In those aspects, the current sea-coral-derived material used to initiate bone regeneration is still far from perfect. The good news is that a regenerative-medicine expert from the Swansea University managed to develop a superior coral-based bone substitute – a fusion of coralline hydroxyapatite and calcium carbonate. So far, the new material proves to be quite promising in both animal and human tests.
An Alternative Solution
Every year, almost a million Americans undergo bone grafting. And each one of those who have to go through this complex medical procedure spends a significant amount of money during the process. Given the cost of the entire procedure, any person who has to undergo bone transplantation would definitely want to keep success rates high and complication chances low.
Those who underwent bone grafting and were given an autograft instead of a (coral-derived) xenograft would probably wonder which of the two is superior. In the context of bone fractures, the latter is most likely the better choice. Deriving bone matter directly from the patient creates another zone that needs to be monitored for proper post-operative healing. On the other hand, relying on a xenograft means that only a single invasive procedure would have to be carried out.
Improvement is Key
Healthcare experts should never be satisfied with the current best solution. In other words, there should always be progress, making the best solution even better for the sake of patient welfare and satisfaction.